| 000 | 01660 a2200457 4500 | ||
|---|---|---|---|
| 005 | 20250517214214.0 | ||
| 264 | 0 | _c20181227 | |
| 008 | 201812s 0 0 eng d | ||
| 022 | _a2052-1707 | ||
| 024 | 7 |
_a10.1002/prp2.399 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDel Frari, Laurence | |
| 245 | 0 | 0 |
_aPropranolol pharmacokinetics in infants treated for Infantile Hemangiomas requiring systemic therapy: Modeling and dosing regimen recommendations. _h[electronic resource] |
| 260 |
_bPharmacology research & perspectives _c06 2018 |
||
| 300 |
_ae00399 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAdministration, Oral |
| 650 | 0 | 4 |
_aAdrenergic beta-Antagonists _xadministration & dosage |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Dosage Calculations |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aHemangioma _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInfant |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aModels, Theoretical |
| 650 | 0 | 4 | _aMonte Carlo Method |
| 650 | 0 | 4 | _aPractice Guidelines as Topic |
| 650 | 0 | 4 |
_aPropranolol _xadministration & dosage |
| 700 | 1 | _aLéauté-Labrèze, Christine | |
| 700 | 1 | _aGuibaud, Laurent | |
| 700 | 1 | _aBarbarot, Sébastien | |
| 700 | 1 | _aLacour, Jean-Philippe | |
| 700 | 1 | _aChaumont, Christine | |
| 700 | 1 | _aDelarue, Alain | |
| 700 | 1 | _aVoisard, Jean-Jacques | |
| 700 | 1 | _aBrunner, Valérie | |
| 773 | 0 |
_tPharmacology research & perspectives _gvol. 6 _gno. 3 _gp. e00399 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/prp2.399 _zAvailable from publisher's website |
| 999 |
_c28366770 _d28366770 |
||